(NewsDirect)
Neuronetics CEO Keith Sullivan joinsNatalie Stoberman from the Proactive newsroom to discuss how itsNeuroStar Advanced Therapy is emerging as an alternative for treatingdepression.
Sullivan explains that NeuroStar delivers amagnetic pulse to a specific part of the brain to reduce depressionsymptoms. With over 5 million successful treatments on nearly 150,000patients, Sullivan says NeuroStar offers a promising alternative forthose who have failed multiple drugs. However, he adds that there is alack of awareness among patients and psychiatrists and the companyintends to address this challenge by investing approximately $14million in driving awareness within psychiatric practices and beyond.
Contact Details
Proactive Invesetors
+1347-449-0879
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.